Howmedica v. Howard (D.N.J. 2024)
(reasonableness of protection of trade secret matter)
Category: Expert Witness History
BHI Energy v. KVP Holdings (N.D. Tx. 2023-24)
(addressing reasonableness of trade secrecy measures)
Categories
Clyde & Co. (Paris)
iXblue v. Safran (ICC N.Y. and Paris 2022) Addressing confidentiality practices in show-how transfer in a patent and trade secret field-of-use nonexclusive license
Categories
Daewoong Pharma (S. Korea)
In the matter of certain Botulinum Toxin Products (ITC Inv. 337-TA-1145 2021) Sponsored public interest submission to ITC criticizing ALJ’s ruling that claimant’s bacteria is a trade secret. ITC reversed ALJ ruling.
Categories
Harcus Parker (London)
Major Commodity Enterprise v. Media Company (High Court of Justice London 2020) (addressing interplay between trade secret owner’s property right and First Amendment rights of publisher in relation to a parallel action pending in the S.D.N.Y.)
Categories
Nobel Biocare
Bichacho et al v. Nobel Biocare Services AG (ICC Zurich 2018) (analysis of controlling principles for assessing U.S. patent damages in respect of independent and dependent claims)
Categories
Amerihua Produce
Blue Book Services v. Amerihua Produce (N.D. Ill. 2018) (analysis of secrecy safeguards in standard form of license agreement for data)
De Simone v. VSL Pharmaceuticals (D. Md. 2018) (custom and usage concerning duration of secrecy obligation)
Categories
Lowenstein Sandler
The Medicines Co. v. Biogen MA (D.N.J. 2017) (custom and usage as to correlation between terms of license grant and royalty provisions)
Nektar Pharmaceuticals v. Allergan and MAP Pharmaceuticals (JAMS Arbitration Arbitration San Jose 2017) (construction of exclusive patent license in respect of entitlement of licensor to fees paid to licensee by a third party)